Market Discoverer

Investment Idea for US and Hong Kong Market

Investment

Which Macau Casino Stock Will Be The Winner For Guangdong-Macao Intensive Cooperation Zone Development?

Recently, Macau casino sector have been rebounded from its 52-week low as visitors are expected to increase in nearby future. Moreover, on September 5, 2021, China’s central government released the Master Plan of the Development of the Guangdong-Macao Intensive Cooperation…

Is Kuaishou Technology (1024.HK) A Buy After The Expired of Post-listing Lockup Period?

On 5 August 2021, Kuaishou Technology (1024.HK) downed by more than 15% as the IPO lockup period was ended on 4 August 2021. Cornerstone investors are now can exit their investment and put further pressure on the share price of…

Should You Buy China Evergrande Group (3333.HK) During Its Liquidity Uncertainty?

On 20 July 2021, the world’s most indebted developer China Evergrande Group (3333.HK) closed at HKD 7.37 which downed by 10.23%. The share price plunged by 23% since the started of pre-litigation asset preservation process from China Guangfa Bank Yixing…

Is DiDi Global Inc. (DIDI) A Buy After App Takedown in China?

On 4 July 2021, DiDi Global Inc. (DIDI) announced that according to the announcement posted by the Cyberspace Administration of China (the “CAC”) on July 4, 2021, the CAC stated that it was reported and confirmed that the “DiDi Chuxing”…

Should You Add Medlive Technology Co., Ltd. (2192.HK) In Your Portfolio?

Medlive Technology Co., Ltd. (2192.HK) started its IPO on 30 June 2021 with indicative offer price range between HKD 24.1 to HKD 27.2. Medlive Technology will start its trading in Hong Kong Stock Exchange on 15 July 2021. Should investors…

Should You Add Nayuki Holdings Limited (2150.HK) In Your Portfolio?

Nayuki Holdings Limited (2150.HK) closed its IPO on 23 June 2021 with 204.8 times over subscription. According to ETNet, total margin application was over HKD 104.8 billion. Nayuki Holdings Limited will start its trading in Hong Kong Stock Exchange on…

How Angelalign Technology Inc (6699.hk) Become The Hottest Hong Kong IPO in 2021

Angelalign Technology Inc (6699.hk) is a leading clear aligner treatment solution provider in China. It’s IPO price was set at HKD 173 with 200 share per lot. There were about 792,400 subscriptions for its IPO. On it’s debut June 16…

What You Need to Know About Xiaoju Kuaizhi Inc (DiDi) IPO?

Xiaoju Kuaizhi Inc has started its IPO project and expected to list in New York Stock Exchange. Underwriters including Goldman Sachs (Asia) L.L.C., Morgan Stanley, J.P. Morgan and China Renaissance. What is Xiaoju Kuaizhi Inc? Here are the summary your should know about this company….

3 Reasons Why Investor Should be Caution for Apple Inc. (AAPL)

On April 28, 2021, Apple Inc. released its second quarter results. Revenue up 54 percent to new March quarter record from US 58,313 million to 89,584 million. Services and Mac revenue reach new all-time high with US 16,901 million and…

Why Alibaba Health (0241.HK) down after the announcement of 2021 fiscal year result?

Alibaba Health Information Technology Limited (0241.HK) is a integrated pharmaceutical e-commerce platform in China. Its business unit “Tmall Medicine” is currently the largest pharmaceutical e-commerce platform in China. Alibaba Health also is the largest online medicine retailer in terms of…